NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Fortrea Holdings Inc. (NASDAQ: FTRE). Shareholders who purchased shares of FTRE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/fortrea-holdings-inc-loss-submission-form/?id=154294&from=3 CLASS PERIOD: Ju ...

Group 1 - Altimmune, Inc. (NASDAQ: ALT) is competing in the metabolic disease drug development sector against major pharmaceutical companies like Novo Nordisk (NVO) and Eli Lilly (LLY) [1] - The article highlights the significance of innovative companies in developing breakthrough therapies and pharmaceuticals that have potential acquisition catalysts [1] Group 2 - The author of the article is a full-time healthcare investor with a focus on biotech and life-saving therapies, emphasizing the importance of understanding the market dynamics in this sector [1]

OR Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-41844 Central Plains Bancshares, Inc. (Exact Name of Registrant as Specified in its Charter) Maryland 93-2239246 (State or other ...

Third Quarter of Fiscal 2025 Continuing Operations Highlights* Net sales were $159 million, a 5.5% increase compared to the prior year, with a 2.0% increase in organic sales.1Operating profit margin was 20.0% and adjusted operating profit margin was 24.1%.Net earnings were $22.0 million, or $0.41 per diluted share. Adjusted net earnings were $27.7 million, or $0.51 per diluted share.Adjusted EBITDA was $41.0 million and adjusted EBITDA margin was 25.9%.Returned approximately $14 million to shareholders thro ...

Webcast and conference call on July 25 at 7 a.m. PT (10 a.m. ET)SEATTLE, June 26, 2025 /PRNewswire/ -- Weyerhaeuser Company (NYSE: WY) will release second quarter 2025 results on Thursday, July 24, after the market closes. The company will then hold a live webcast and conference call the following day, on Friday, July 25, at 7 a.m. Pacific (10 a.m. Eastern), to discuss the results.To access the earnings release, live webcast and presentation online, visit the Investor Relations section on www.weyerhaeuser.c ...

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, held today a shareholders general meeting at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France. At the meeting, during which approximately 57% of voting rights were exercised, resolutions 1 through 23 and resolutions 25 and 26 were adopted, while resolu ...

First-in-human trial of AX-0810 will evaluate safety, tolerability, pharmacokinetics, and target engagement in healthy volunteers with initial data expected in Q4 2025Marks the first submitted Clinical Trial Application (CTA) advancing ProQR’s Axiomer™ ADAR-mediated RNA editing platform into clinical development LEIDEN, Netherlands & CAMBRIDGE, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies bas ...

TEL AVIV, Israel, June 26, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q2 2025 Aide Memoire is available on the “Investors” page on its website. Q2 2025 Aide Memoire Teva has prepared this document to assist in the financial modeling of its quarterly results. The document is based on Teva’s prior results, management’s previous commentary about Teva’s business outlook and data from select independent sources. About Teva Teva Pharmaceutical Indus ...

Phoenix, Arizona--(Newsfile Corp. - June 26, 2025) - Gunnison Copper Corp. (TSX: GCU) (OTCQB: GCUMF) (FSE: 3XS0) ("Gunnison" or the "Company") reports that the nominees listed in the management information circular for the 2025 Annual General Meeting of shareholders were elected as directors of Gunnison. Detailed results of the vote for the election of directors held at the Annual General Meeting on June 26, 2025 in Vancouver, B.C., are set out below:Votes for% Votes forVotes withheld% Votes withheldStephe ...

NEW YORK, June 26, 2025 /PRNewswire/ -- SiriusXM (NASDAQ: SIRI) will release its second quarter 2025 operating and financial results on Thursday, July 31, and will hold an investor call that same day at 8:00 a.m. ET. A live webcast will be available on the SiriusXM Investor Relations website at https://investor.siriusxm.com.To participate by telephone, please dial 877.407.4019 (Toll-free) or +1 201.689.8337 (Local) 10 minutes prior to the start of the call and ask to be connected to the SiriusXM conference ...